Results 201 to 210 of about 57,365 (244)

Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease. [PDF]

Sci Rep, 2019
Miller JJ, Aoki K, Reid CA, Tiemeyer M, Dahms NM, Kassem IS.   +5 more
europepmc   +1 more source

Pathological Mechanism‐Inspired Biomimetic Nano‐Senotherapy for Reversing Experimental Atherosclerosis in ApoE−/− Mice

Advanced Science, Volume 13, Issue 47, 24 August 2026.
The biomimetic self‐assembly nanomedicine reversing atherosclerosis via senotherapy strategy. ABSTRACT The greatest challenge in atherosclerosis (AS) management lies in achieving lesion reversal, not merely slowing progression. Senescent cell accumulation—driven by continuous generation and apoptotic resistance—perpetuates plaque pathology and ...
Yuhan Tian, Yanrui Yang, Qiuyu Li, Ying Hu, Qin Hu, Shasha Ran, Siyu Zhou, Xiujuan Yang, Shanshan Li, Qixiong Zhang   +9 more
wiley   +1 more source

Inhibition of Mitochondrial Complex I Impairs Release of α-Galactosidase by Jurkat Cells. [PDF]

Int J Mol Sci, 2019
Lambert JRA, Howe SJ, Rahim AA, Burke DG, Heales SJR.   +4 more
europepmc   +1 more source

Abalone Gut Microbiome Regulators: A Review Synthesizing Gut Physiology, Microorganisms, Diet and the Environment

Aquaculture, Fish and Fisheries, Volume 6, Issue 4, August 2026.
ABSTRACT Abalone are economically, ecologically and culturally significant marine molluscs, with both wild and farmed populations under pressure due to intrinsic and extrinsic stressors. Abalone performance and health are centred on a highly specialized digestive system supported by a diverse gut microbiome, which enables nutrient assimilation ...
Jinchen Guo, Leonie Venter, Donnabella C. Lacap‐Bugler, Andrea C. Alfaro   +3 more
wiley   +1 more source

Optimization of Saccharomyces cerevisiae α-galactosidase production and application in the degradation of raffinose family oligosaccharides. [PDF]

Microb Cell Fact, 2019
Álvarez-Cao ME, Cerdán ME, González-Siso MI, Becerra M.   +3 more
europepmc   +1 more source

Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT We described a 12‐year‐old boy with classic Fabry disease who was diagnosed through newborn screening. At age 6.2, he started agalsidase alfa based on evidence of subclinical organ involvement. At age 7.2, acroparesthesia subsequently developed.
Nobuhiko Koga, Hiroaki Yodogawa, Takaaki Sawada, Yuichi Mushimoto, Shinichiro Nagamitsu, Kimitoshi Nakamura, Shinichi Hirose, Takahito Inoue   +7 more
wiley   +1 more source

A Novel α-Galactosidase A Splicing Mutation Predisposes to Fabry Disease. [PDF]

Front Genet, 2019
Li P, Zhang L, Zhao N, Xiong Q, Zhou YA, Wu C, Xiao H.   +6 more
europepmc   +1 more source

Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma

Cancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Glioblastoma (GB) is the most aggressive primary malignant brain tumor in adults and remains associated with poor survival despite surgical resection followed by radiotherapy and temozolomide (TMZ) chemotherapy. Intrinsic and acquired resistance to TMZ, including MGMT‐dependent DNA repair and activation of pro‐survival pathways ...
Ali Nakhaei, Atefeh Taghavi, Amir R. Afshari, Farzaneh Davoudi, Elaheh Gheybi, Mohammad Jalili‐Nik   +5 more
wiley   +1 more source

Postbiotics in Food Systems: Components, Production Methods, Food Applications, Functional Properties, and Technological Challenges

Food Science &Nutrition, Volume 14, Issue 8, August 2026.
This review provides a comprehensive, engineering‐oriented synthesis of postbiotics as next‐generation functional food ingredients. It first outlines the principal production routes for postbiotic generation, encompassing thermal technologies, non‐thermal technologies, and extraction/purification methods, and subsequently examines the analytical and ...
Tansu Taspinar, Nuray Güzeler
wiley   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source